| Date |
Time |
Hall |
Session |
Role |
Title |
Name |
| 2018-10-19 |
13:42-13:54 |
Conference Hall No.2-A（2F） |
Arterial science and innovation（Simultaneous Interpretation ） |
Symposium |
Preliminary study of directional debulking devices plus drug-coated balloon for vertebral artery stenosis |
Lixing Qi |
| 2018-10-19 |
14:30-14:42 |
Conference Hall No.2-A（2F） |
Arterial science and innovation（Simultaneous Interpretation ） |
Symposium |
Phase II multicenter, randomized, double-blind, placebo-controlled clinical trial of the plasmid pUDK-HGF expressing human hepatocyte growth factor for critical limb ischemia |
Lixing Qi |
| 2018-10-20 |
09:38-09:46 |
Conference Hall No.5-B（1F） |
Treatment for lower limb ischemic disease |
Symposium |
TAPAS balloon treatment for lower limb arteriosclerosis obliterans |
Lixing Qi |
| 2018-10-20 |
15:42-15:46 |
Conference Hall No.5-B（1F） |
DCB Session------Acotec Scientific Co.Ltd |
Surgical Recording |
Video 8 DCB treat carotid in-stent restenotic lesion |
Lixing Qi |
Announcement